These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33481353)

  • 1. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
    Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
    Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
    Gao F; Li N; Xu Y; Yang G
    J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
    Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
    Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
    Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
    Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 6. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
    Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
    Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer.
    Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z
    World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
    Wei S; Xie M; Tian J; Song X; Wu B; Liu L
    Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
    Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
    Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of postoperative radiotherapy on the survival of patients with stage III non-small cell lung cancer: A CONSORT-compliant analysis using the SEER database.
    Wu K; Peng W; Shuai Z; Peng X; Liu H; Zhang S
    Medicine (Baltimore); 2023 Jun; 102(24):e34015. PubMed ID: 37327271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
    Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
    J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach.
    Deng W; Xu T; Xu Y; Wang Y; Liu X; Zhao Y; Yang P; Liao Z
    J Thorac Oncol; 2018 Dec; 13(12):1968-1974. PubMed ID: 30194035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
    Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
    BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database.
    Wang X; Song J; Long J; Zeng Z; Liu A
    Radiat Oncol; 2021 Sep; 16(1):184. PubMed ID: 34544464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database.
    Yang R; Gong J; Liao Z; Yu J; Zhang J; Xie C
    Transl Cancer Res; 2022 Jul; 11(7):2194-2204. PubMed ID: 35966291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
    J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.